Latest happenings on the Capital Markets


Although the first half of the year remained relatively quiet, some remarkable listing stories emerged, mostly from growing small and medium -sized companies.

Smart manufacturing company Arcure listed on the Euronext Growth market in February. Arcure develops solutions that combine 3D vision sensors with AI algorithms to enhance the autonomy and safety of industrial machinery. The company raised €7.9 million at IPO and achieved a reached €35 million market capitalisation, becoming the first listing of the year on the Euronext markets.

Belgium-based medtech company Sequana Medical made its initial public offering on Euronext Brussels, raising €27.7 million to finance its growth strategy. The company became the 41st medtech to list on Euronext markets, a sector that represents a significant peer group for investors trading on Euronext.

Watch the video of Sequana Medical’s listing

Listings continue to expand beyond Euronext countries

Beyond Euronext borders, entrepreneurs across Europe are also considering the Euronext platform to list their company. We welcomed three Italian companies to our Paris market this semester:

Italy Innovazioni, a growing engineering and design company dedicated to the innovative design of household electrical outlets,

Società Editoriale Il Fatto, an independent Italian multimedia provider and publisher,

and EdiliziAcrobatica, the leading Italian company for safety rope access within the building industry. The Euronext Paris building façade was decorated to welcome the enthusiastic EdiliziAcrobatica team and management, who made the trip from Genova to ring the bell at the listing ceremony. Grazie a tutto il team!

Take a look at EdiliziAcrobatica’s listing ceremony

On 7 June, Iceland-based company Marel, a global leader in technology-backed food processing, listed on Euronext Amsterdam with a public offering comprising 100 million shares. To further strengthen its strong growth, the company was looking for a platform offering a deep and global investor pool. Marel picked Euronext Amsterdam out of a select group of major international exchanges to strengthen its capital structure and provide a global currency for acquisitions.
Watch the video to hear Marel's CEO explain the company's story and why he chose Euronext.

Ireland paves the way to international investors for new life sciences listing

Uniphar, a diversified healthcare services group headquartered in Dublin, listed on Euronext Growth mid-July, for total proceeds of €150 million. The listing is to allow the company attract new investors and capital from across Europe.

The stock exchange is not just about going public; on the secondary markets, activity has been driven by the need for financing from large corporates as investors have switched to assets perceived as safer. Some companies efficiently carried out follow-on deals to raise capital on Euronext markets.  Here are a few of the highlights:

Mergers & Acquisitions deals brought out impressive stories to the markets

M&A deals from Essilor (Luxottica), Covivio (Eurosic) and were the largest financing deals this semester, raising €2.1 billion in total.

Private healthcare group Ramsay Générale de Santé announced a takeover deal on competitor Capio, which holds the leading position in Sweden and is a major player in Norway and Denmark. The Group made a €567 million public offer to finance the acquisition.

Online food delivery marketplace listed on Euronext Amsterdam in September 2016, with a market capitalisation of around €1 billion. Already ranked as a Tech Unicorn at the time, it has kept growing (valuation estimated at some €5 billion today), and earlier this year acquired the German business of DeliveryHero for a total consideration of €930 million. The transaction was successfully completed in April 2019 thanks to a €430 million capital increase and a €250 million bond listed on Euronext.’s gong ceremony in 2016

Biocartis and Nanobiotix: life sciences on the move

Among the latest notable life sciences deals, two biotech companies have been active in the secondary market this semester. Biocartis, a Belgian biotech, successfully raised €55.50 million in a private placement.

French late-stage clinical company Nanobiotix made a private placement in April 2019 for €29.52 million to finance its next developments. The company, which listed in 2012, has made 6 offerings on the stock exchange since listing for a total consideration of €141.7 million.

Energy and services drive Dublin offerings

International oil and gas company Falcon Oil & Gas made a successful placement of new common shares on Euronext Growth Dublin for €8.08 million to pursue its business developments. Also in Dublin, First Derivatives, a leading provider of products and consulting services, issued new shares for €4.31 million.

The real estate market in the spotlight

The real estate sector is gaining traction on Euronext markets. This semester, we saw Foncière INEA closing its largest capital increase for €96 million, significantly broadening its shareholder base. Euronext also saw three SIGIs (Portuguese Real Estate Investment Trusts, or REITs) as well as one SOCIMI (Spanish REIT) listed on our markets.

Among the largest transactions, Belgian real estate company Aedifica launched a successful 418 million capital increase. The company made the offer to refinance the recent acquisition of a UK healthcare real estate portfolio, support its development pipeline and increase equity to continue its growth strategy. Montea, also a Belgian real estate company, successfully completed a public offering of €176.56 million.   

This closes the chapter of the most interesting listing stories from H1 2019. The next ‘Inside Euronext Markets’ newsletter will bring you the next chapter of news on companies and their stories as they finance their business and future development through Euronext. Subscribe here.